HPV Self-Sampling for Cervical Cancer
(Isbaar Trial)
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the HPV Self-Sampling treatment for cervical cancer?
Is HPV self-sampling safe for humans?
How is the HPV Self-Sampling treatment for cervical cancer unique?
The HPV Self-Sampling treatment is unique because it allows women to collect their own samples at home using a swab, making it more convenient and potentially increasing participation in cervical cancer screening. This method is particularly beneficial in low-resource settings where access to healthcare facilities may be limited.148910
What is the purpose of this trial?
This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.
Research Team
Rebekah Pratt, PhD
Principal Investigator
University of Minnesota
Rachel Winer, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for Somali women aged 30-65 who are due for cervical cancer screening. Participants must identify as Somali and be eligible for the screening, meaning they haven't had a hysterectomy that removed their cervix or a history of cervical cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are offered HPV self-sampling as an alternative to cervical cancer screening by a clinician
Follow-up
Participants are monitored for cervical cancer screening uptake and follow-up Pap tests if necessary
Treatment Details
Interventions
- COPAN 552c.80 FLOQSwab
- COPAN 552c FLOQSwab
- HPV Self-Sampling
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor